Pairwise sees ‘dramatic uptick’ in CRISPR licensing as gene editing moves beyond row crops

Pairwise sees ‘dramatic uptick’ in CRISPR licensing as gene editing moves beyond row crops

Gene editing is rapidly expanding beyond row crops into specialty crops, animals, and microbes, says Pairwise, which has seen a “dramatic uptick” in licensing deals for its Fulcrum platform over the past 12-18 months and now has 25 licensees covering more than 30 species. Unlike transgenic plants—which are classified as GMOs as foreign DNA from another species is introduced—gene editing involves tinkering with species’ native genes, which eases …